BridgeBio Pharma reported cash from operations of -$71.10M and free cash flow of -$71.54M for the quarter ended Jun 2026, up 11.9% year over year. This cash flow statement covers 33 quarters of results from Jun 2018 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Cash Flow Statement | Jun2018 | Sep2018 | Dec2018 | Mar2019 | Jun2019 | Sep2019 | Dec2019 | Mar2020 | Jun2020 | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||||||||||||||||||||||||||||
| Net Income | -160.33M | -180.57M | -194.27M | -100.50M | -146.52M | -145.13M | -145.97M | -166.62M | -174.21M | -192.11M | -23.16M | -75.54M | -164.25M | -267.39M | -122.50M | -183.76M | -184.94M | -194.59M | -118.92M | -155.89M | |||||||||||||
| Share-based CompensationStock Comp. | 16.13M | 22.51M | 24.28M | 12.67M | 18.66M | 22.58M | 23.48M | 27.18M | 27.23M | 30.83M | 28.85M | 21.45M | 27.13M | 30.13M | 25.88M | 37.34M | 35.26M | 34.64M | 33.24M | 44.07M | |||||||||||||
| Gains from Investment SecuritiesGains Investment | -0.66M | 0.74M | 0.85M | 10.22M | 0.06M | 0.12M | -0.11M | -0.11M | 0.27M | -1.04M | |||||||||||||||||||||||
| Asset Writedowns and ImpairmentWritedown | -3.30M | 12.65M | 0.07M | ||||||||||||||||||||||||||||||
| Cash from OperationsCash from Ops. | -121.56M | -133.90M | -160.63M | -30.45M | -135.16M | -93.24M | -144.32M | -113.35M | -145.23M | -124.82M | -219.54M | 74.70M | -180.57M | -195.33M | -199.24M | -80.68M | -109.57M | -56.42M | -197.28M | -71.10M | |||||||||||||
| Depreciation, Depletion & Amortization | |||||||||||||||||||||||||||||||||
| Amortizatization of IntangiblesAmort. of Intangibles | 1.39M | 1.75M | 2.48M | 1.90M | 2.09M | 2.10M | 2.34M | 2.24M | 2.14M | -2.69M | 2.02M | 1.67M | -0.56M | 0.99M | 0.99M | 1.24M | 1.21M | 1.46M | 1.47M | 1.63M | |||||||||||||
| Amortization of Deferred ChargesAmort. Deferred Charges | 0.94M | 2.06M | 1.62M | 1.44M | 1.46M | 1.45M | 1.82M | 1.93M | |||||||||||||||||||||||||
| Depreciation & Amortization (CF)Dep. & Amort. | 0.27M | 1.53M | 1.88M | 1.58M | 1.65M | 1.66M | 1.63M | 1.64M | 1.64M | 1.58M | 1.60M | 1.57M | 1.54M | 1.37M | 1.28M | 1.32M | 1.40M | 1.44M | 1.19M | 1.05M | |||||||||||||
| Change in Working Capital | |||||||||||||||||||||||||||||||||
| Change in ReceivablesChange Receivables | 233.74M | -234.83M | -0.18M | 4.24M | 110.54M | -38.40M | 39.65M | 22.93M | 65.78M | 49.26M | |||||||||||||||||||||||
| Change in InventoryChange Inventory | 3.19M | 13.39M | 6.77M | 1.95M | 7.05M | 21.11M | |||||||||||||||||||||||||||
| Change in Account PayablesChange Payables | -11.66M | 1.47M | -1.81M | -1.28M | 1.36M | 1.38M | -3.80M | -0.30M | 0.69M | 6.18M | -5.93M | 14.79M | -3.60M | -3.75M | 17.57M | -1.05M | -7.43M | 17.52M | -7.17M | -1.86M | |||||||||||||
| Change in Accured ExpensesChange Accured Exp. | 4.05M | 18.61M | -16.88M | 7.47M | 0.28M | 1.39M | -18.37M | 7.30M | 6.92M | 11.96M | -14.97M | 6.59M | 1.77M | 23.60M | -19.36M | 45.97M | 26.42M | 24.78M | -37.48M | 89.88M | |||||||||||||
| Investing Activities | |||||||||||||||||||||||||||||||||
| Capital ExpendituresCapex | 6.46M | 2.54M | 0.86M | 2.40M | 0.76M | 0.80M | 0.10M | 0.34M | 0.43M | 0.43M | 0.69M | 0.05M | 0.14M | 0.05M | 0.34M | 0.26M | 0.47M | 0.03M | 0.07M | 0.44M | |||||||||||||
| Sales of Property, Plant and EquipmentPP&E (Sale) | 10.00M | ||||||||||||||||||||||||||||||||
| Divestments | 29.41M | 25.68M | 2.30M | ||||||||||||||||||||||||||||||
| Change in Acquisitions & DivestmentsChange Acquisitions | 66.27M | 75.00M | 186.69M | 107.22M | 158.90M | 26.87M | 42.29M | 24.78M | 15.48M | 28.01M | 63.23M | 31.77M | 8.00M | 3.00M | 10.00M | 29.60M | |||||||||||||||||
| Cash from Investing ActivitiesCash from Investing | 58.97M | 21.80M | 138.62M | 149.70M | 146.86M | 17.96M | 12.30M | 4.12M | 37.68M | -0.07M | 22.75M | 3.04M | 38.23M | -3.24M | -1.59M | -13.00M | 4.46M | -14.35M | -42.73M | 17.89M | |||||||||||||
| Financing Activities | |||||||||||||||||||||||||||||||||
| Other financing activitiesOther financing | 3.08M | 2.35M | 1.12M | 1.44M | 5.74M | -1.18M | 0.66M | 0.79M | 2.36M | 2.14M | 3.24M | 6.44M | 4.84M | 13.21M | 22.59M | 5.22M | |||||||||||||||||
| Cash from Financing ActivitiesCash from Financing | -135.46M | 325.38M | -0.16M | -20.80M | 1.45M | 6.38M | 150.25M | -1.23M | 307.04M | -4.52M | 279.55M | -5.73M | 0.71M | 473.93M | 60.33M | 302.04M | -0.89M | -2.18M | 549.89M | -148.77M | |||||||||||||
| Change in Capital Stock | |||||||||||||||||||||||||||||||||
| Net Shares Issued and RepurchasedNet Shares Issued | 5.97M | 0.48M | 2.18M | 1.11M | 1.72M | 0.14M | 0.96M | 0.38M | |||||||||||||||||||||||||
| Net Equity Issued and RepurchasedNet Equity Issued | 4.90M | 143.02M | 1.03M | 241.30M | -0.45M | 315.25M | 38.16M | -0.02M | |||||||||||||||||||||||||
| Dividend Payments | |||||||||||||||||||||||||||||||||
| Dividends Paid - CommonDiv. Paid (Common) | |||||||||||||||||||||||||||||||||
| Additional items | |||||||||||||||||||||||||||||||||
| Change in Cash | -198.05M | 213.29M | -22.17M | 98.45M | 13.14M | -68.90M | 18.23M | -110.47M | 199.50M | -129.41M | 82.76M | 72.01M | -141.63M | 275.37M | -140.50M | 208.36M | -106.00M | -72.96M | 309.88M | -201.98M | |||||||||||||
| Free Cash FlowFCF | -128.02M | -136.43M | -161.49M | -32.85M | -135.92M | -94.04M | -144.42M | -113.70M | -145.66M | -125.25M | -220.23M | 74.65M | -180.70M | -195.37M | -199.57M | -80.94M | -110.04M | -56.45M | -197.35M | -71.54M | |||||||||||||
| Net Cash FlowNCF | -198.05M | 213.29M | -22.17M | 98.45M | 13.14M | -68.90M | 18.23M | -110.47M | 199.50M | -129.41M | 82.76M | 72.01M | -141.63M | 275.37M | -140.50M | 208.36M | -106.00M | -72.96M | 309.88M | -201.98M |